Clinical Trials and Research Studies

At NYU Langone Health, our doctors and researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.

Recently Added/Updated Trials

  • Digi-Moms: Studying blood sugar levels and physical activity patterns in individuals with gestational diabetes

    In this study, we plan to conduct a prospective exploratory study in 40 participants with gestational diabetes to examine the feasibility of collecting data with ...

    View Details

  • A Phase 1b/2 Randomized Open-Label Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy in Patients With Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer

    The goal of the study is to find out if a new drug called LBL-007, given in combination with other drugs called tislelizumab, bevacizumab, and ...

    View Details


    This observational study will examine cochlear implant (CI) patients with single-sided deafness (SSD) who receive non-default frequency allocation tables (FATs) after initial stimulation to determine ...

    View Details

  • The effects of Gender-Affirming Hormone Therapy on ambulatory blood pressure of transgender adolescents

    The goal of this study is to inform regarding effects of GAHT on blood pressure, to help improve clinical practice guidelines regarding screening and treatment ...

    View Details

  • AMPLITUDE clinical research trial

    The AMPLITUDE clinical research trial will be looking at two different amounts (doses) of the investigational study drug, called VX-147, as treatment for APOL-1 related ...

    View Details

  • Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP II)

    The purpose of this research study is to determine whether an investigational drug called AVB-114, is safe and effective to treat perianal fistulas in people ...

    View Details

  • A Randomized Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiranin the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease with METAVIR Stage F2 to F4 Fibrosis

    In this study, fazirsiran is being compared with a placebo for patients with alpha-1 antitrypsin deficiency-associated liver disease (AATD LD). A placebo is a liquid ...

    View Details

  • A Phase 3 Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants with Active Systemic Lupus Erythematosus (POETYK-SLE-2)

    This study is a double-blinded 52-week clinical trial to evaluate the efficacy and safety of deucravacitinib in adult participants with active Systemic Lupus Erythematosus (SLE ...

    View Details